Targeting Olig2 co-regulators for malignant glioma therapy

被引：0
|
作者：
Kupp, Robert [1 ]
Lo Cascio, Costanza [1 ]
Rauf, Femina [2 ]
Meijer, Dimphna [3 ]
Stiles, Charles D. [3 ]
Sanai, Nader [1 ]
LaBaer, Joshua [2 ]
Mehta, Shwetal V. [1 ]
机构：
[1] Barrow Neurol Inst, Phoenix, AZ 85013 USA
[2] Arizona State Univ, Tempe, AZ USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.BRAIN15-B20
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B20
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Quantitative Analysis of Mitotic Olig2 Cells in Adult Human Brain and Gliomas: Implications for Glioma Histogenesis and Biology
    Rhee, Wootack
    Ray, Sutapa
    Yokoo, Hideaki
    Hoane, Megan E.
    Lee, Chong C.
    Mikheev, Andrei M.
    Horner, Philip J.
    Rostomily, Robert C.
    GLIA, 2009, 57 (05) : 510 - 523
  • [22] OLIG2 maintenance is not essential for diffuse intrinsic pontine glioma cell line growth but regulates tumor phenotypes
    Liao, Yunfei
    Luo, Zaili
    Deng, Yaqi
    Zhang, Feng
    Rao, Rohit
    Wang, Jiajia
    Xu, Lingli
    Kumar, Shiva Senthil
    Sengupta, Satarupa
    DeWire-Schottmiller, Mariko
    Berry, Kalen
    Garrett, Matthew
    Fouladi, Maryam
    Drissi, Rachid
    Lu, Qing Richard
    NEURO-ONCOLOGY, 2021, 23 (07) : 1183 - 1196
  • [23] The Central Nervous System-Restricted Transcription Factor Olig2 Opposes p53 Responses to Genotoxic Damage in Neural Progenitors and Malignant Glioma
    Mehta, Shwetal
    Huillard, Emmanuelle
    Kesari, Santosh
    Maire, Cecile L.
    Golebiowski, Diane
    Harrington, Emily P.
    Alberta, John A.
    Kane, Michael F.
    Theisen, Matthew
    Ligon, Keith L.
    Rowitch, David H.
    Stiles, Charles D.
    CANCER CELL, 2011, 19 (03) : 359 - 371
  • [24] ACT001 inhibited CD133 transcription by targeting and inducing Olig2 ubiquitination degradation
    Huiting Deng
    Hailin Liu
    Guoyue Yang
    Dandan Wang
    Ying Luo
    Chenglong Li
    Zhenchang Qi
    Zhili Liu
    Peng Wang
    Yanfang Jia
    Yingtang Gao
    Yahui Ding
    Oncogenesis, 12
  • [25] Olig2 SUMOylation protects against genotoxic damage response by antagonizing p53 gene targeting
    Huiqing Liu
    Weiji Weng
    Rongjun Guo
    Jie Zhou
    Jun Xue
    Shan Zhong
    Jinke Cheng
    Michael X. Zhu
    Si-Jian Pan
    Yong Li
    Cell Death & Differentiation, 2020, 27 : 3146 - 3161
  • [26] OLIG2 Influences Cell Proliferation and Differentiation Through Direct Effects on Glioma-Relevant Receptor Tyrosine Kinases
    Aldape, Kenneth
    NEURO-ONCOLOGY, 2017, 19 (01) : 9 - 10
  • [27] ACT001 inhibited CD133 transcription by targeting and inducing Olig2 ubiquitination degradation
    Deng, Huiting
    Liu, Hailin
    Yang, Guoyue
    Wang, Dandan
    Luo, Ying
    Li, Chenglong
    Qi, Zhenchang
    Liu, Zhili
    Wang, Peng
    Jia, Yanfang
    Gao, Yingtang
    Ding, Yahui
    ONCOGENESIS, 2023, 12 (01)
  • [28] Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification
    Mokhtari, K
    Paris, S
    Aguirre-Cruz, L
    Privat, N
    Crinière, E
    Marie, Y
    Hauw, JJ
    Kujas, M
    Rowitch, D
    Hoang-Xuan, K
    Delattre, JY
    Sanson, M
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2005, 31 (01) : 62 - 69
  • [29] EGFR missense mutation(s) induce OLIG2 expression to regulate glioma stem cells maintenance and therapeutic resistance
    Weaver, Sidney
    Miller, Aunay
    Blomquist, Mylan
    McNamara, James
    Orndorff, Keely
    Sereduk, Chris
    Kloss, Jean
    Loftus, Joseph
    Mehta, Shwetal
    Tran, Nhan L.
    CANCER RESEARCH, 2024, 84 (06)
  • [30] Olig2 SUMOylation protects against genotoxic damage response by antagonizing p53 gene targeting
    Liu, Huiqing
    Weng, Weiji
    Guo, Rongjun
    Zhou, Jie
    Xue, Jun
    Zhong, Shan
    Cheng, Jinke
    Zhu, Michael X.
    Pan, Si-Jian
    Li, Yong
    CELL DEATH AND DIFFERENTIATION, 2020, 27 (11): : 3146 - 3161
12345